Elsevier's Skin & Allergy News Digital Network launched Product Zone, a targeted product and digital resource center designed to assist dermatologists, physicians and related healthcare professionals in making informed purchasing decisions. The microsite will feature videos, white papers, webcasts, case studies as well as more than 4,000 derm product, company and resource listings.
Wolters Kluwer Health's Ovid unit announced it has partnered with nine new premium publishers to deliver full-text content through its OvidSP search, discovery and management platform. Ovid, which offers customizable electronic research info for the medical, scientific and academic markets, works with over 150 publishers.
GlaxoSmithKline wrote a “Dear doctor” letter to recipients of a GSK-sponsored paid supplement hyping Avodart, Dow Jones Newswires reported. The supplement ran in the May 2009 edition of the journal Urology and included clinical trials data on Avodart's prostate cancer-fighting abilities, for which the drug does not have FDA approval. In the letter, GSK North America head Dierdre Connelly conceded that the company had helped to develop content and select the authors of the supplement.